Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 13/20 | 0.62 |
| ▸ | PIK3CD | O00329 | 9/20 | 0.62 |
| ▸ | MTOR | P42345 | 8/20 | 0.59 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.59 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.59 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.39 |
| ▸ | ATR | Q13535 | 2/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.39 |
| ▸ | ATRIP | Q8WXE1 | 2/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3935715 | 0.93 | MTOR (0.63) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3927459 | 0.89 | PIK3CA (0.62) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3926690 | 0.89 | MTOR (0.57) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3927064 | 0.87 | MTOR (0.55) | PIK3CAPIK3CDMTOR | |
| SCHEMBL3929252 | 0.87 | PIK3CA (0.62) | PIK3CAPIK3CDMTOR | |
| SCHEMBL3924111 | 0.87 | PIK3CA (0.55) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3926913 | 0.86 | PIK3CA (0.53) | PIK3CAPIK3CDMTOR | |
| SCHEMBL3926434 | 0.85 | MTOR (0.53) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3929141 | 0.84 | PIK3CA (0.49) | PIK3CAPIK3CDMTOR | |
| SCHEMBL3927636 | 0.84 | PIK3CA (0.48) | PIK3CAPIK3CDMTORPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074118-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | AstraZeneca AB (SE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |